Provider
P67-21 Medical Drug Policy Update – Infliximab Preferred Product Expansion to Include Remicade, Inflectra, and Renflexis
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Nov 01, 2021
Program effective Date: Oct 27, 2021